Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC liposomes

Based on

1 Articles
2016 Most recent source

Composition

1

2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonic acid aqueous solution

Type Complex Compound
Formula
Role core
2

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 upconversion nanoparticles

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 core/shell UCNP phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles lipid-UCNP
Type Nano Material
Formula
Role loaded material
3

doxorubicin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
4

[(2R)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate

non-deuterated 1,2-distearoyl-sn-glycero-3-phosphocholine 1,2-distearoyl-sn-glycerol-3-phosphatidylcholine 1,2-distearoyl-sn-glycero-3-phosphatidylcholine 1,2-dioctadecanoyl-sn-glycero-3-phosphocholine L-α 1,2-distearoyl-sn-glycero-3-phosphocholine 1,2-distearoyl-sn-glycero-3-phosphorylcholine hydrogenated soy sn-glycero-3-phosphocholine 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 1,2-Distearoyl-sn-glycero-3-phosphocholine 1,2-distearoyl-sn-glycero-3-phosphocholine hydrogenated soy L-α-phosphatidylcholine hydrogenated soybean phosphatidylcholine distearoyl-sn-glycero-3-phosphocholine hydrogenated soya phosphatidylcholine hydrogenated soy phosphatidylcholine Hydrogenated soy phosphatidylcholine hydrogenated L-α-phosphatidylcholine distearyl-L-α-phosphatidylcholine distearoyl phosphatidylcholine distearyl phosphatidyl choline distearoylphosphatidylcholine L-α-phosphatidylcholine egg PC hDSPC DSPC HSPC DSCP
Type Single Compound
Formula C44H88NO8P
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
NIR laser-mediated drug release

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • [(2R)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
  1. YCZmoaLUyiDboP4tozt
  2. 49M6F7
  3. wVb
Product

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC liposomes

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial